nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Cefuroxime—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Cefuroxime—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Cefuroxime—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Cefuroxime—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Cefuroxime—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Cefuroxime—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Cefuroxime—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Cefuroxime—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Cefuroxime—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Cefuroxime—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Cefuroxime—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Cefuroxime—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Cefuroxime—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Cefuroxime—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Cefuroxime—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Cefuroxime—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Cefuroxime—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Cefuroxime—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000994	0.000994	CcSEcCtD
Cefuroxime—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000987	0.000987	CcSEcCtD
Cefuroxime—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000987	0.000987	CcSEcCtD
Cefuroxime—Rash—Topotecan—peripheral nervous system neoplasm	0.000986	0.000986	CcSEcCtD
Cefuroxime—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000985	0.000985	CcSEcCtD
Cefuroxime—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000985	0.000985	CcSEcCtD
Cefuroxime—Cough—Etoposide—peripheral nervous system neoplasm	0.000981	0.000981	CcSEcCtD
Cefuroxime—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000981	0.000981	CcSEcCtD
Cefuroxime—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000981	0.000981	CcSEcCtD
Cefuroxime—Headache—Topotecan—peripheral nervous system neoplasm	0.00098	0.00098	CcSEcCtD
Cefuroxime—Rash—Tretinoin—peripheral nervous system neoplasm	0.000978	0.000978	CcSEcCtD
Cefuroxime—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000978	0.000978	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000978	0.000978	CcSEcCtD
Cefuroxime—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000978	0.000978	CcSEcCtD
Cefuroxime—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000977	0.000977	CcSEcCtD
Cefuroxime—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000977	0.000977	CcSEcCtD
Cefuroxime—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000974	0.000974	CcSEcCtD
Cefuroxime—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000974	0.000974	CcSEcCtD
Cefuroxime—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000973	0.000973	CcSEcCtD
Cefuroxime—Headache—Tretinoin—peripheral nervous system neoplasm	0.000972	0.000972	CcSEcCtD
Cefuroxime—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000972	0.000972	CcSEcCtD
Cefuroxime—Pain—Vincristine—peripheral nervous system neoplasm	0.000969	0.000969	CcSEcCtD
Cefuroxime—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000969	0.000969	CcSEcCtD
Cefuroxime—Rash—Melphalan—peripheral nervous system neoplasm	0.000966	0.000966	CcSEcCtD
Cefuroxime—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000965	0.000965	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000962	0.000962	CcSEcCtD
Cefuroxime—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000957	0.000957	CcSEcCtD
Cefuroxime—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000955	0.000955	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000951	0.000951	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000943	0.000943	CcSEcCtD
Cefuroxime—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000934	0.000934	CcSEcCtD
Cefuroxime—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000934	0.000934	CcSEcCtD
Cefuroxime—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00093	0.00093	CcSEcCtD
Cefuroxime—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00093	0.00093	CcSEcCtD
Cefuroxime—Nausea—Topotecan—peripheral nervous system neoplasm	0.000929	0.000929	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000927	0.000927	CcSEcCtD
Cefuroxime—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000922	0.000922	CcSEcCtD
Cefuroxime—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000922	0.000922	CcSEcCtD
Cefuroxime—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000918	0.000918	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000913	0.000913	CcSEcCtD
Cefuroxime—Nausea—Melphalan—peripheral nervous system neoplasm	0.00091	0.00091	CcSEcCtD
Cefuroxime—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000907	0.000907	CcSEcCtD
Cefuroxime—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000899	0.000899	CcSEcCtD
Cefuroxime—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000896	0.000896	CcSEcCtD
Cefuroxime—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000896	0.000896	CcSEcCtD
Cefuroxime—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000896	0.000896	CcSEcCtD
Cefuroxime—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000896	0.000896	CcSEcCtD
Cefuroxime—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000893	0.000893	CcSEcCtD
Cefuroxime—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000892	0.000892	CcSEcCtD
Cefuroxime—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000887	0.000887	CcSEcCtD
Cefuroxime—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000875	0.000875	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000872	0.000872	CcSEcCtD
Cefuroxime—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000871	0.000871	CcSEcCtD
Cefuroxime—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.00087	0.00087	CcSEcCtD
Cefuroxime—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000868	0.000868	CcSEcCtD
Cefuroxime—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000866	0.000866	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000865	0.000865	CcSEcCtD
Cefuroxime—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000859	0.000859	CcSEcCtD
Cefuroxime—Pain—Cisplatin—peripheral nervous system neoplasm	0.000857	0.000857	CcSEcCtD
Cefuroxime—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000846	0.000846	CcSEcCtD
Cefuroxime—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000846	0.000846	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000841	0.000841	CcSEcCtD
Cefuroxime—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000835	0.000835	CcSEcCtD
Cefuroxime—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000832	0.000832	CcSEcCtD
Cefuroxime—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000829	0.000829	CcSEcCtD
Cefuroxime—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000818	0.000818	CcSEcCtD
Cefuroxime—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000816	0.000816	CcSEcCtD
Cefuroxime—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000807	0.000807	CcSEcCtD
Cefuroxime—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000807	0.000807	CcSEcCtD
Cefuroxime—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000807	0.000807	CcSEcCtD
Cefuroxime—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000806	0.000806	CcSEcCtD
Cefuroxime—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000805	0.000805	CcSEcCtD
Cefuroxime—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000805	0.000805	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.0008	0.0008	CcSEcCtD
Cefuroxime—Rash—Dactinomycin—peripheral nervous system neoplasm	0.0008	0.0008	CcSEcCtD
Cefuroxime—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000798	0.000798	CcSEcCtD
Cefuroxime—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000795	0.000795	CcSEcCtD
Cefuroxime—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000793	0.000793	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000792	0.000792	CcSEcCtD
Cefuroxime—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000792	0.000792	CcSEcCtD
Cefuroxime—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000786	0.000786	CcSEcCtD
Cefuroxime—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000786	0.000786	CcSEcCtD
Cefuroxime—Pain—Etoposide—peripheral nervous system neoplasm	0.000785	0.000785	CcSEcCtD
Cefuroxime—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000784	0.000784	CcSEcCtD
Cefuroxime—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000783	0.000783	CcSEcCtD
Cefuroxime—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000783	0.000783	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000778	0.000778	CcSEcCtD
Cefuroxime—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000778	0.000778	CcSEcCtD
Cefuroxime—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000775	0.000775	CcSEcCtD
Cefuroxime—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000773	0.000773	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000763	0.000763	CcSEcCtD
Cefuroxime—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000757	0.000757	CcSEcCtD
Cefuroxime—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000753	0.000753	CcSEcCtD
Cefuroxime—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000753	0.000753	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000751	0.000751	CcSEcCtD
Cefuroxime—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000749	0.000749	CcSEcCtD
Cefuroxime—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000748	0.000748	CcSEcCtD
Cefuroxime—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000746	0.000746	CcSEcCtD
Cefuroxime—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000746	0.000746	CcSEcCtD
Cefuroxime—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000746	0.000746	CcSEcCtD
Cefuroxime—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000741	0.000741	CcSEcCtD
Cefuroxime—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000741	0.000741	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00074	0.00074	CcSEcCtD
Cefuroxime—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000738	0.000738	CcSEcCtD
Cefuroxime—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000737	0.000737	CcSEcCtD
Cefuroxime—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000734	0.000734	CcSEcCtD
Cefuroxime—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000729	0.000729	CcSEcCtD
Cefuroxime—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000728	0.000728	CcSEcCtD
Cefuroxime—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000728	0.000728	CcSEcCtD
Cefuroxime—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000728	0.000728	CcSEcCtD
Cefuroxime—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000726	0.000726	CcSEcCtD
Cefuroxime—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000726	0.000726	CcSEcCtD
Cefuroxime—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000726	0.000726	CcSEcCtD
Cefuroxime—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000724	0.000724	CcSEcCtD
Cefuroxime—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000724	0.000724	CcSEcCtD
Cefuroxime—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00072	0.00072	CcSEcCtD
Cefuroxime—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000716	0.000716	CcSEcCtD
Cefuroxime—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000715	0.000715	CcSEcCtD
Cefuroxime—Rash—Vincristine—peripheral nervous system neoplasm	0.000714	0.000714	CcSEcCtD
Cefuroxime—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000714	0.000714	CcSEcCtD
Cefuroxime—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.00071	0.00071	CcSEcCtD
Cefuroxime—Headache—Vincristine—peripheral nervous system neoplasm	0.00071	0.00071	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000706	0.000706	CcSEcCtD
Cefuroxime—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.0007	0.0007	CcSEcCtD
Cefuroxime—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000698	0.000698	CcSEcCtD
Cefuroxime—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000697	0.000697	CcSEcCtD
Cefuroxime—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000686	0.000686	CcSEcCtD
Cefuroxime—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000685	0.000685	CcSEcCtD
Cefuroxime—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000676	0.000676	CcSEcCtD
Cefuroxime—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000673	0.000673	CcSEcCtD
Cefuroxime—Nausea—Vincristine—peripheral nervous system neoplasm	0.000673	0.000673	CcSEcCtD
Cefuroxime—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.00067	0.00067	CcSEcCtD
Cefuroxime—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00067	0.00067	CcSEcCtD
Cefuroxime—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000662	0.000662	CcSEcCtD
Cefuroxime—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000657	0.000657	CcSEcCtD
Cefuroxime—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000657	0.000657	CcSEcCtD
Cefuroxime—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000654	0.000654	CcSEcCtD
Cefuroxime—Chills—Epirubicin—peripheral nervous system neoplasm	0.00065	0.00065	CcSEcCtD
Cefuroxime—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000649	0.000649	CcSEcCtD
Cefuroxime—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000637	0.000637	CcSEcCtD
Cefuroxime—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000634	0.000634	CcSEcCtD
Cefuroxime—Rash—Cisplatin—peripheral nervous system neoplasm	0.000632	0.000632	CcSEcCtD
Cefuroxime—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000631	0.000631	CcSEcCtD
Cefuroxime—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00063	0.00063	CcSEcCtD
Cefuroxime—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000628	0.000628	CcSEcCtD
Cefuroxime—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000621	0.000621	CcSEcCtD
Cefuroxime—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000608	0.000608	CcSEcCtD
Cefuroxime—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000607	0.000607	CcSEcCtD
Cefuroxime—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000606	0.000606	CcSEcCtD
Cefuroxime—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000605	0.000605	CcSEcCtD
Cefuroxime—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000601	0.000601	CcSEcCtD
Cefuroxime—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000595	0.000595	CcSEcCtD
Cefuroxime—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000584	0.000584	CcSEcCtD
Cefuroxime—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000583	0.000583	CcSEcCtD
Cefuroxime—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000579	0.000579	CcSEcCtD
Cefuroxime—Rash—Etoposide—peripheral nervous system neoplasm	0.000579	0.000579	CcSEcCtD
Cefuroxime—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000578	0.000578	CcSEcCtD
Cefuroxime—Headache—Etoposide—peripheral nervous system neoplasm	0.000575	0.000575	CcSEcCtD
Cefuroxime—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000575	0.000575	CcSEcCtD
Cefuroxime—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000564	0.000564	CcSEcCtD
Cefuroxime—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000561	0.000561	CcSEcCtD
Cefuroxime—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000557	0.000557	CcSEcCtD
Cefuroxime—Cough—Epirubicin—peripheral nervous system neoplasm	0.00055	0.00055	CcSEcCtD
Cefuroxime—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000546	0.000546	CcSEcCtD
Cefuroxime—Nausea—Etoposide—peripheral nervous system neoplasm	0.000545	0.000545	CcSEcCtD
Cefuroxime—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000537	0.000537	CcSEcCtD
Cefuroxime—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000537	0.000537	CcSEcCtD
Cefuroxime—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000536	0.000536	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000533	0.000533	CcSEcCtD
Cefuroxime—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000522	0.000522	CcSEcCtD
Cefuroxime—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000515	0.000515	CcSEcCtD
Cefuroxime—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000515	0.000515	CcSEcCtD
Cefuroxime—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000509	0.000509	CcSEcCtD
Cefuroxime—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000505	0.000505	CcSEcCtD
Cefuroxime—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000504	0.000504	CcSEcCtD
Cefuroxime—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000502	0.000502	CcSEcCtD
Cefuroxime—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.0005	0.0005	CcSEcCtD
Cefuroxime—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000497	0.000497	CcSEcCtD
Cefuroxime—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000497	0.000497	CcSEcCtD
Cefuroxime—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000497	0.000497	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000493	0.000493	CcSEcCtD
Cefuroxime—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.00049	0.00049	CcSEcCtD
Cefuroxime—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000476	0.000476	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000469	0.000469	CcSEcCtD
Cefuroxime—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000466	0.000466	CcSEcCtD
Cefuroxime—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000465	0.000465	CcSEcCtD
Cefuroxime—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000462	0.000462	CcSEcCtD
Cefuroxime—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.00046	CcSEcCtD
Cefuroxime—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000459	0.000459	CcSEcCtD
Cefuroxime—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000457	0.000457	CcSEcCtD
Cefuroxime—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000454	0.000454	CcSEcCtD
Cefuroxime—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000453	0.000453	CcSEcCtD
Cefuroxime—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000447	0.000447	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000444	0.000444	CcSEcCtD
Cefuroxime—Pain—Epirubicin—peripheral nervous system neoplasm	0.00044	0.00044	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000434	0.000434	CcSEcCtD
Cefuroxime—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000424	0.000424	CcSEcCtD
Cefuroxime—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000423	0.000423	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000421	CcSEcCtD
Cefuroxime—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000419	0.000419	CcSEcCtD
Cefuroxime—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.000414	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000411	0.000411	CcSEcCtD
Cefuroxime—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000409	0.000409	CcSEcCtD
Cefuroxime—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.000407	CcSEcCtD
Cefuroxime—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000407	0.000407	CcSEcCtD
Cefuroxime—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000407	0.000407	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000389	CcSEcCtD
Cefuroxime—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000379	CcSEcCtD
Cefuroxime—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000378	CcSEcCtD
Cefuroxime—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Cefuroxime—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Cefuroxime—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000364	0.000364	CcSEcCtD
Cefuroxime—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000352	CcSEcCtD
Cefuroxime—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000351	CcSEcCtD
Cefuroxime—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00034	0.00034	CcSEcCtD
Cefuroxime—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.000337	CcSEcCtD
Cefuroxime—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000327	0.000327	CcSEcCtD
Cefuroxime—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000326	CcSEcCtD
Cefuroxime—Rash—Epirubicin—peripheral nervous system neoplasm	0.000324	0.000324	CcSEcCtD
Cefuroxime—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000324	0.000324	CcSEcCtD
Cefuroxime—Headache—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000322	CcSEcCtD
Cefuroxime—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000315	CcSEcCtD
Cefuroxime—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000306	CcSEcCtD
Cefuroxime—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000303	CcSEcCtD
Cefuroxime—Rash—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.0003	CcSEcCtD
Cefuroxime—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.0003	CcSEcCtD
Cefuroxime—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000298	CcSEcCtD
Cefuroxime—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000283	CcSEcCtD
